About 600 results
Open links in new tab
  1. Arrowhead Pharmaceuticals Home I Arrowhead Pharmaceuticals

    Changing the way diseases are treated, Arrowhead pharmaceuticals uses innovative, scientific methods to discover, develop, and deliver therapies and solutions.

  2. Our Pipeline | Arrowhead Pharmaceuticals

    Check out the development of Arrowhead’s products to treat challenging cardiometabolic, pulmonary, neuromuscular, liver, and more types of diseases.

  3. Investors | Arrowhead Pharmaceuticals Inc.

    Jun 4, 2025 · Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and …

  4. About Us | Arrowhead Pharmaceuticals

    Learn more about Arrowhead Pharmaceutical's foundation as a therapeutic discovery company, innovative use of RNAi, and ambitious pipeline for developing medicines.

  5. Careers | Arrowhead Pharmaceuticals

    A career at Arrowhead offers the opportunity to collaborate with world class discovery-stage innovators and clinicians to rapidly discover, develop, and commercialize RNAi-based …

  6. Science & Innovation | Arrowhead Pharmaceuticals

    See Arrowhead's scientific and innovative discovery and development platform, producing effective new therapies that are cost effective and may have a lower risk.

  7. Newsroom | Arrowhead Pharmaceuticals

    Stay up to date on Arrowhead Pharmaceutical's latest news, stories, and events. Read about recent studies on potential treatments, healthcare conferences, and more!

  8. Arrowhead Pharmaceuticals Reports 2024 Fiscal Year-End Results

    Sep 30, 2024 · PASADENA, Calif. -- (BUSINESS WIRE)--Nov. 26, 2024-- Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its 2024 fiscal …

  9. Arrowhead Pharmaceuticals Announces Global License and …

    Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced a global licensing and collaboration agreement with Sarepta Therapeutics (NASDAQ: SRPT). Upon closing, …

  10. Arrowhead Pharmaceuticals Reports Fiscal 2025 Second Quarter …

    May 12, 2025 · Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2025 second quarter ended March 31, 2025. The Company is hosting a …

  11. Some results have been removed